Author:
Andersen Niels H.,Mogensen Carl E.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Balcells E, Meng QC, Johnson WH Jr, et al.: Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol 1997, 273:H1769-H1774.
2. Ihara M, Urata H, Kinoshita A, et al.: Increased chymasedependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999, 33:1399–1405.
3. Burnier M, Brunner HR: Angiotensin II receptor antagonists. Lancet 2000, 355:637–645.
4. Lindholm LH, Ibsen H, Dahlof B, et al.: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:1004–1010.
5. Parving HH, Lehnert H, Brochner-Mortensen J, et al.: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870–878.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献